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Summary: LL-37 is a human cationic host defense peptide (antimicrobial peptide) belonging to the cathelicidin family of peptides. In this study, LL-37 was shown to kill stimulated and nonstimulated CD4 + CD25 +
FoxP3
+ T cells (regulatory T cells; Tregs) through apoptosis, while having no cytotoxic effect on CD4 + CD25
À T cells at the same LL-37 concentrations. Of interest, Tregs were much more sensitive to LL-37 than many other cells, dying at 10-fold lower concentrations than other cell types tested. LL-37 exposure resulted in DNA fragmentation, chromatin condensation, and apoptotic body formation, all indicative of an apoptotic form of cell death. The importance of granzyme family members in the apoptosis of Tregs after LL-37 treatment was analyzed by using C57Bl/6 lymphocytes obtained from mice that were homozygous for null mutations in the granzyme B gene, and both the granzyme A and B genes. Granzyme A and granzyme B were both shown to play a role in LL-37-induced apoptosis of Tregs. Further analysis showed that apoptosis occurred primarily through caspase-dependent apoptosis at high LL-37 concentrations. However, grA-dependent/caspase-independent cell death was also observed. This suggests that LL-37 induces apoptosis in Tregs through multiple different mechanisms, initiated by the LL-37-induced leakage of granzymes from cytolytic granules. Our results imply that LL-37 administered at the site of a tumor could influence the adaptive antitumor immune response by killing Tregs and thus inhibiting their suppressor activity.
Key Words: regulatory T cells, granzyme, host defense peptide, apoptosis (J Immunother 2011; 34:229-235) C ationic host defense peptides play an important role in innate immunity, 1 influencing processes such as cytokine and chemokine release, and cell proliferation.
2 LL-37 is a cationic, amphipathic host defense peptide released by proteinase 3 proteolytic processing of the C-terminal domain of the cathelicidin, human cationic antimicrobial protein-18. 3 It is endogenously expressed by a variety of cells, including keratinocytes, epithelial cells, and neutrophils, 4 being released in response to multiple inflammatory stimuli. 5, 6 Upon release, LL-37 acts as an effector molecule of innate immunity, displaying anti-infective and immunomodulatory activities, including the enhancement of neutrophil survival. 7, 8 and the induction of neutrophil, CD4 + T-cell and monocyte chemotaxis. 9 However, a concentration of 100 mg/mL of LL-37 results in the death of 60% untransformed human airway epithelial cells. 10 These variations on the cytotoxic nature of LL-37 may potentially be related to peptide-mediated augmentation of innate immunity. 8 
CD4
+ CD25 + (Forkhead box P3) FoxP3 + regulatory T cells (Tregs) are often associated with peripheral immune tolerance, which is involved in controlling detrimental immune responses to self-antigens, and preventing excessive inflammatory responses to foreign antigens. They also play a significant role in suppressing immunity to tumorassociated antigens.
11 Adoptively transferred Tregs have been shown to block tumor-reactive effector T cells in various murine model studies, whereas the in vivo removal of Tregs is known to enhance antitumor immunity. 12, 13 Tregs can suppress the proliferation of numerous cell types, including bystander T cells, through both soluble and cellassociated molecules, such as interleukin-10, anticytotoxic T-lymphocyte antigen-4, and transforming growth factorb.
14 They also exhibit granzyme B (grB)-mediated suppressive mechanisms, which result in the selective killing of bystander effector T cells 15 and antigen presenting B cells. 16 In addition, grB has been shown to be important within the tumor microenvironment for Treg-mediated suppression of tumor clearance. 17 Activated Tregs also express high levels of granzyme A and can display perforin-dependent cytotoxicity. 18 Granule-mediated cell death involves a family of granule-associated serine proteases, known as granzymes. Granzyme A (grA) and grB are stored within cytotoxic granules as active enzymes, being released by effector cells such as Tregs, and taken up by target cells where they activate two distinct death pathways. GrA is a tryptase that triggers death in a caspase-independent manner by acting on a number of substrates, including poly ADP ribose polymerase-1, 19 Ku70, 20 and NADH dehydrogenase (ubiquinone) iron-sulfur protein 3. 21 In contrast, grB is a serine protease that cleaves proapoptotic substrates, including caspase-3 and Bid, after aspartate residues, [22] [23] [24] [25] resulting in caspase-mediated apoptosis. Caspases are a family of intracellular cysteine proteases that are normally found in an inactive, zymogen form in healthy cells. During apoptosis, the proteolytic activation of initiator and subsequent effecter caspase family members often results in the degradation of molecules that lead to the characteristic morphology associated with apoptosis, including inhibitor of caspase-activated DNase, poly ADP ribose polymerase, and proteins involved in membrane stability (ie, gelsolin), cellular shape (ie, fodrin), and nuclear structures. [26] [27] [28] In this study, we have determined that low concentrations of the host-defense peptide, LL-37, can kill Tregs through a granzyme-mediated mechanism, involving the activation of caspase family members. At similar peptide concentrations, LL-37 has no cytotoxic effect on CD4
À T cells. The potential for enhancing the antitumor T-cell response, through an LL-37-mediated reduction in suppressive Tregs, may be a promising treatment option for cancer patients.
MATERIALS AND METHODS

Cell Culture and Reagents
The mouse lymphocytes were generated from control mice (strain ID: C57BL/6 12953/SV1mJ; background: C57BL/6 and 129; obtained from Dr T. J. Ley, Washington University, St Louis, MO), and mice homozygous for null mutations in the grB gene [strain ID: B6.129S Gzmb (Tm1 Ley); background: B6/129; obtained from Dr T. J. Ley], or both grA and grB genes (129/SUJ-GzmABKO line 64/18 CRE). Cells were maintained at 371C in a 5% CO 2 humidified atmosphere in RPMI 1640 medium (SigmaAldrich Canada, Oakville, ON, Canada) supplemented with 10% (v/v) heat-inactivated fetal calf serum (Hyclone, Logan, UT), 100 mg/mL streptomycin, 100 units/mL penicillin, 2 mmol/L L-glutamine, and 5 mmol/L N-2-hydroxyl piperazine-N 0 -2-ehane sulfonic acid buffer (pH 7.4) (Invitrogen, Burlington, ON, Canada), from this point on referred to as RHF.
Synthetic LL-37 (amino acid sequence: NH 2 -LL GDFFRKSKEKIGKEFKRIVQ-RIKDFLRNLVPRTES-COOH) was synthesized by F-moc [N-(9-fluorenyl)-methoxycarbonyl] chemistry at the Nucleic Acid/Protein Synthesis Unit at the University of British Columbia (Vancouver, Canada). Lyophilized peptide was resuspended in endotoxin-free water (Sigma-Aldrich) and aliquots were stored at À201C. Bovine serum albumin (BSA), paraformaldehyde (PFA), saponin, and Hoechst 33342 trihydrochloride dye were purchased from Sigma-Aldrich. Caspase inhibitors (Q-VD-OPh and Z-VAD-fmk) were purchased from Kamiya Biomedical Company (Seattle, WA). Terminal transferase dUTP nick end labeling (TUNEL) in situ cell detection kits (fluorescein) were from Roche Diagnostics (Laval, PQ). PE-Cy7-conjugated rat anti-mouse CD4 (L3T4), and PEconjugated rat anti-mouse CD25 were from BD Biosciences (Mississauga, ON). APC anti-mouse Foxp3 (clone FJK-16s) and the APC anti-mouse Foxp3 staining set were from eBioscience (San Diego, CA). Purified anti-mouse CD28, and purified anti-mouse CD3e were from Cedarlane Laboratories Ltd (Burlington, ON).
Regulatory T-cell Isolation
The isolation of naturally occurring regulatory T cells (CD4 + CD25 + ) and CD4 + CD25 À T cells from mouse spleen cell suspension was performed using the MACS CD4 + CD25 + regulatory T-cell isolation kit (Miltenyi Biotec, Auburn, CA), a MidiMACS separator and a MiniMACS separator. In brief, spleens were passed through 30 mM nylon mesh, followed by red blood cell depletion using red blood cell lysis buffer [10 mM KHCO 3 , 150 mM NH 4 Cl, and 0.1 mM ethylene diaminetetra-acetic acid (pH 8.0) in distilled H 2 O] (5 min, 41C). Cells were washed 2 Â with ice-cold isolation buffer (0.5% BSA, and 2 mM ethylene diaminetetra-acetic acid in phosphatebuffered saline (PBS), pH 7.2), counted, and resuspended in ice-cold isolation buffer (40 mL/10 7 total cells) containing biotin-antibody cocktail (10 mL/10 7 total cells, 10 min, 41C). Followed by the addition of isolation buffer (30 mL/10 7 total cells), anti-biotin microbeads (20 mL/10 7 total cell), and CD25-PE antibody (10 mL/10 7 total cells, 15 min, 41C, 15 min, 41C). Cells were then washed with isolation buffer, and centrifuged at 300g (10 min, 41C). Supernatant was removed; cells were resuspended in isolation buffer (500 mL/ 10 8 cells), and loaded onto a pre-rinsed LD MACS separator column. The unlabelled, enriched CD4 + T-cell fraction was collected after column passage and washes, centrifuged at 300 g (10 min, 41C), and resuspended in isolation buffer (90 mL/10 7 total cells) containing anti-PE microbeads (10 mL/10 7 total cells). Cells were incubated in the dark (15 min, 41C), washed with isolation buffer, and centrifuged at 300 g (10 min, 41C). Supernatant was removed, cells were resuspended in isolation buffer (500 ml/10 8 cells), and loaded onto a pre-rinsed MS MACS separator column. The enriched CD4 + CD25 À T-cell fraction was collected after column passage and washes. The enriched CD4 + CD25 + T-cell fraction was collected by removing the column from the separator, and quickly flushing out the fraction containing magnetically labeled CD4 + CD25 + cells by firmly applying a plunger. The magnetic separation procedure was repeated 1 Â using a new MS column. The purity of the enriched CD4a + T-cell fraction was analyzed using anti-CD4-PECy7 and flow cytometry, and was determined to be greater than 90% (data not shown). Cell debris, dead cells, and non-CD4 + cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence (data not shown).
T-cell Activation
Six-well plates (Becton Dickinson Labware, Franklin Lakes, NJ) were coated with 5 mg/mL hamster anti-mouse a-CD3e/aCD28 in 1 mL PBS (overnight, 41C). Cells were stimulated (1Â 10 6 cells/well) in a 5% CO 2 humidified atmosphere with plate-bound hamster anti-mouse a-CD3e/ anti-CD28 monoclonal antibodies in RHF supplemented with 60 U/mL interleukin-2 for 48 hours (371C).
DNA Fragmentation Assay
TUNEL assay was used to measure DNA fragmentation in cells undergoing cell death. 29 In brief, cells ( T cells was performed using TUNEL-FITC and antibodies against CD4, CD25, and Foxp3. The addition of broad-spectrum caspase inhibitors (Q-VD-OPh, 20 mM or Z-VAD-fmk, 50 mM) 1 hour before LL-37 addition was used to determine the requirement of caspase involvement in LL-37-mediated cell death. Total cell counts were performed before and after LL-37 treatment; cells were not lost due to washes or lysis in control or LL-37-treated samples (data not shown). Data are shown as mean percentage of cell death ±SD, n = 3 independent experiments, each performed in triplicate.
Hoechst Staining
Murine CD4 + CD25 + Foxp3 + Tregs (5 Â10 4 cells/ treatment) were treated with media, or LL-37 (20 and 40 mg/mL, 371C, 5% CO 2 ) for 2 hours. Cells were washed with PBS after LL-37 treatment, resuspended in 50 mL of 4% PFA in PBS, and placed on microscope slides to air dry overnight (Corning, Corning, NY). Staining was then performed for 10 minutes at room temperature with Hoechst 33342 trihydrochloride dye (10 mg/mL in PBS). Slides were washed 4 Â with distilled water and allowed to air dry in the dark. Confocal microscopy was used to assess chromatin condensation and nuclear fragmentation by counting 500 cells from nonoverlapping fields. Total cell counts were performed before and after LL-37 treatment; cells were not lost due to washes or lysis in control or LL-37-treated samples (data not shown).
Analysis of chromatin condensation, membrane changes, and apoptotic body formation using Hoechst 33342 trihydrochloride dye was performed at room temperature on an LSM510 laser scanning confocal microscope mounted on a Zeiss Axiovert 100 M microscope fitted with a Plan Neofluar objective 60/1.4 and analyzed with LSM5 software (Zeiss).
RESULTS
LL-37 Induces Apoptosis in Regulatory T Cells
Apoptosis is a form of cellular death that is characterized by specific morphological features, including DNA fragmentation, and chromatin condensation. Figure 1A shows that stimulated and nonstimulated murine CD4 + 25 + FoxP3 + Tregs exposed to increasing concentrations of LL-37 (5, 10, 20, 40, and 100 mg/mL, equivalent to 1, 2, 4.4, 8.8, and 20 mM, respectively, 4 h) displayed significant DNA fragmentation as assessed by TUNEL-FITC DNA staining. Media control values were negligible and were subtracted from the treatment values before graphing. As DNA fragmentation is an indicator of apoptotic cell death, these data suggest that the Tregs were undergoing apoptosis after LL-37 exposure. Both stimulated and nonstimulated CD4 + 25 À , and CD4 + 25 +low FoxP3 À T cells were not affected by LL-37, which suggests that the apoptosis-inducing activity of LL-37 is specific to FoxP3 + Tregs. LL-37 treatment led to apoptosis in nonstimulated Tregs, but not to the same extent as in activated cells. Hoechst 33342 staining (Figs. 1B, C) showed chromatin condensation and apoptotic body formation in Tregs treated with LL-37 (52%±5 and 74%±3, respectively, 20 and 40 mg/mL, 2 h), further confirming that LL-37 is inducing an apoptotic form of cell death in this cell type.
Tregs From grB and AB Knockout Mice Are Resistant to LL-37-induced Apoptosis
Tregs have been shown to express granzymes, 17, 18 and these enzymes have been shown to induce apoptosis by caspase activation. 23, 30 We decided to test whether granzymes might be involved in our system using CD4 + CD25 + Foxp3 + Tregs isolated from granzyme knockout mice. Apoptosis in wild type (WT), grB À / À , and grAB
Tregs was analyzed using TUNEL-FITC staining in the absence or presence of LL-37 (10, 20, and 40 mg/mL, 4 h) (Fig. 2) . Tregs that were knockout in the grB and grAB genes were significantly less sensitive to apoptosis induced by LL-37. These data suggest that both grA and grB, which mediate apoptosis by caspase-independent 31,32 and caspasedependent mechanisms, respectively, are both involved in LL-37-induced killing of Tregs. At the same time, granzyme ko Tregs were not completely resistant to LL-37-induced apoptosis at higher LL-37 concentrations.
Caspase Family Members Contribute to LL-37-induced Treg Apoptosis
Caspases are known to be critical as effectors of apoptosis. 26, 28 We, therefore, tested if they were important in the death of CD4 + CD25 + Foxp3 + Tregs. Apoptosis was analyzed using TUNEL-FITC staining in the absence or presence of the pan-caspase inhibitors, Q-VD-OPh (20 mM, 1 h pretreatment) or Z-VAD-fmk (50 mM, 1 h pretreatment). Both Q-VD-OPh and Z-VAD-fmk (Fig. 3) had an inhibitory effect on LL-37-induced apoptosis in WT, as well as gr À / À Tregs (LL-37 40 mg/mL, 4 h). Caspase inhibitors were dissolved in dimethylsulfoxide. Vehicle control analysis showed no cytotoxic effect on T cells.
DISCUSSION
Regulatory T cells are known to play a significant role in the induction of immune tolerance to self-antigens, and may be primarily responsible for inhibiting antitumor immune responses. In this study, we determined that LL-37 is cytotoxic to naturally occurring murine CD4 + CD25 + FoxP3 + Tregs at concentrations ranging from 5 to 100 mg/mL, while having no cytotoxic effect on murine CD4 + CD25 À T cells. It is interesting to note that, we saw significant fragmentation at 20 and 40 mg/mL with activated Tregs. In addition, preliminary experiments with human Tregs have determined that these cells act just like murine Tregs at 20 mg/mL LL-37, displaying 40% cell death, whereas CD4 + CD25 À T cells showed 3% cell death (data not shown). In other cell types, this level of fragmentation required 100 to 200 mg/mL. 33 It was determined that Tregs exposed to LL-37 died through the induction of apoptosis, characterized by DNA fragmentation and chromatin condensation (Figs. 1A-C 
FoxP3
À cells (Fig. 1A) . In addition, LL-37 had less effect on nonstimulated Tregs versus stimulated cells (Fig. 1A) . Earlier studies have shown that naive T-cell populations display less granzyme expression versus stimulated cells. 34 Therefore, the involvement of granzymes in LL-37-induced Treg apoptosis was investigated.
GrB and grA are the 2 best characterized proapoptotic granzymes, leading to caspase-dependent and caspaseindependent apoptosis, respectively. The requirement for grB and/or grA in LL-37-induced Treg apoptosis was analyzed using lymphocytes obtained from grB À / À and grAB À / À mice. GrB À / À and grAB À / À Tregs were significantly less sensitive to LL-37-induced apoptosis (Fig. 2) . GrAB À / À Tregs were more resistant to cell death at lower LL-37 concentrations than Tregs that were ko for only grB À / À , which suggests that, whereas grB is important in LL-37-mediated apoptosis of Tregs, grA or a combination of grA and grB is necessary for death at lower peptide concentrations. However, when exposed to 40 mg/mL LL-37, grB À / À and grAB À / À Tregs displayed similar resistance to LL-37, and whereas grB À / À and grAB À / À cells are significantly more resistant to death, these cells are killed at higher LL-37 peptide concentrations (Fig. 2) . This may be due to the activation of cell death pathways that are not reliant on grA or B, such as the calpain-dependent mechanism previously described. 33 In this earlier study, higher concentrations of LL-37 (100 mg/mL) were required to induce apoptosis in cell lines such as Jurkat. Activation of calpain and the release of apoptosis inducing factor from mitochondria were found to be critical in the demise of the cell. However, some inhibition of death was observed in the presence of a lysosomal cathepsin inhibitor, indicating 
Foxp3
+ regulatory T cells (5Â10 4 cells/treatment) were exposed to LL-37 (20 and 40 mg/mL) for 2 hours. Cells were then fixed with 2% paraformaldehyde, mounted on silinated microscope slides and air dried overnight. Staining with Hoechst 33342 trihydrochloride dye (10 mg/mL) was performed (10 min, RT) and slides were analyzed by confocal microscopy (magnification: Â400). Arrows indicate apoptotic cells C, The percentage of cells showing chromatin condensation was determined by Hoechst staining and counting (500 cells/slide). Data are shown as mean percentage of chromatin condensed cells (± SD, n = 3) (***P < 0.001 when compared with media control).
some leakage of the enzymes from this organelle. We believe that when the potent apoptosis-inducing granzymes are present in the secretory lysosomes of Tregs, then this becomes the major pathway to death. The lack of granzyme expression in most CD4 + CD25 À T cells may be why these cells were not susceptible to LL-37 cytotoxicity. 34 The broad-spectrum caspase inhibitors, Z-VAD-fmk and Q-VD-OPh, significantly inhibited apoptosis in Tregs treated with LL-37 (Fig. 3) . The caspase-dependent apoptosis observed is most likely due to the activity of grB (in W T cells) or other caspase-activating granzymes (in grB À / À and grAB À / À cells), such as grK. Caspase-dependent apoptosis is decidedly predominant, as confirmed by both the inhibition of apoptosis observed in Treg cells (both WT and granzyme ko) in the presence of broad-spectrum caspase inhibitors, and the inhibitory effect of grB À / À on LL-37-induced apoptosis. However, it is also noted that grA, and therefore caspase-independent apoptosis, plays a role in Treg death after LL-37 treatment, in that caspase inhibitors do not completely block LL-37-mediated death, but ko of both grA and grB completely blocked Treg death at low LL-37 concentrations (Fig. 2) .
LL-37 is a cationic host defense peptide that has both anti-infective and immunomodulatory activity. 9, 35 It is expressed at approximately 5 mg/mL in bronchoalveolar lavage of healthy infants, and is upregulated by inflammation to approximately 30 mg/mL in bronchoalveolar lavage from infants with pulmonary infections. 10 Peptide expression is also upregulated in other inflammatory conditions, such as psoriatic skin lesions where levels are approximately 1.5 mg/mL due to in vivo processing. 36 Therefore, the concentrations of LL-37 used in this study are believed to be physiologically relevant. In addition, many studies have been performed to analyze the effects of LL-37 on untransformed cells, thus aiding in the characterization of an acceptable efficacy/safety ratio for LL-37.
7-9 LL-37 is not cytotoxic to a large variety of untransformed cell types at the concentrations used in our study. High concentrations of LL-37 (100 mg/mL and higher) are cytotoxic to airway epithelial cells. 10 However, much lower concentrations of LL-37 are effective at killing Tregs, therefore it is not believed that epithelial cells would be affected during Treg exposure. An earlier paper published by our laboratory analyzed the mechanism of apoptosis induced in Jurkat T leukemia cells exposed to LL-37. 33 We found that Jurkat cells were killed by higher concentrations of LL-37 (50 to 200 mg/mL), through a calpain-dependent and apoptosis inducing factor-dependent pathway requiring the Bcl-2 family member, BAX.
Use of LL-37 in the treatment of cancer patients is beyond the scope of this study. However, it is believed that there may be ways in which the anti-Treg activity of this peptide may be exploited. The possibilities include, but are not limited to, the use of liposomal-delivery systems, 37 earlier shown to significantly increase selectivity while reducing bystander cytotoxicity when the peptide is delivered at high concentrations to specific cell types. We examined the effect of LL-37 on CD8 + T cells, a major subset of T cells that have an antitumor effector role. Activated CD8 + T cells were sensitive to LL-37 exposure (data not shown). However, we do not believe the death of a few activated CD8 + T-cell will have too much effect. Rather, the eradication of the Tregs may lead to the activation of multiple arms of the antitumor response, including the generation of new CD8 + T-cell. There is emerging evidence that shows a potential role for inflammatory molecules, including LL-37, in tumor progression. LL-37 has been shown to promote ovarian cancer progression through the recruitment of proangiogenic cells and immunomodulatory factors, 38 while potentially acting as a growth factor for epithelial cells in breast cancer. 39 However, LL-37 can play a role in host defense against tumors, 40, 41 and is known to suppress tumorigenesis in gastric cancer, 42 and epidermoid carcinoma. 43 Chuang et al 44 has determined that coadministration of CpG oligodeoxynucleotides and LL-37 produces synergistic antitumor effects against ovarian cancer in mice. Therefore, a multifunctional role for LL-37 in cancer progression, dependent on the tissue origin of the tumor, is becoming increasingly apparent, and this would need to be taken into consideration for future clinical application.
In conclusion, we have identified the specific mechanism of LL-37-mediated apoptosis in Tregs. This knowledge could be used as outlined in Figure 4 . In brief, LL-37 induces apoptosis in Treg cells, resulting in the blockage of Treg suppressor activity, which would allow for an enhanced antitumor immune response. Future analysis will test the ability of LL-37 to kill Tregs in vivo using a murine EL4 model of tumorigenesis.
